By AdminM
FluMist Vaccine Approved by CDC Without Proof It Works
by Rishma Parpia
The Vaccine Reaction
In February 2018, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to re-recommend the live virus nasal spray influenza vaccine, FluMist, for the 2018-19 “flu season” after a two-year hiatus.1
FluMist, manufactured by MedImmune/AstraZeneca, was first licensed in the U.S. in 2003 as a trivalent vaccine and was approved for use in healthy children and adults between the ages of five to 49 years old.2
The live …read more
Source: Health Impact News
- Rating:
- Views:121 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr